Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Final Result of a double-blind, Placebo-controlled trial of the antibibrotic efficacy of INF Gamma-1b in chronic hepatitis C patients with advanced fibrosis or cirrosis

Final Result of a double-blind, Placebo-controlled trial of the antibibrotic efficacy of INF Gamma-1b in chronic hepatitis C patients with advanced fibrosis or cirrosis. Gastroenterology. 2005; 128(4):p-175.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.